Advertisement
UltraShape is the clinically proven non-invasive solution for fatreduction and body contouring using "non-thermal" selective focusedultrasound technology. Seven leading physicians specializing in the field ofaesthetic medicine will present clinical results on the effectiveness ofUltraShape's Contour I in reducing fat thickness and improving body contours.
Advertisement
Dr. Benjamin Ascher, Clinique of Aesthetic Surgery IENA in Paris, France,and Course Director of IMCAS, will present his most recent clinicalexperience involving 130 patients. Results demonstrate that following athree-treatment protocol using the UltraShape Contour I system, over 72% ofpatients achieved 2-7 cm in body circumference reduction. "Both my patientsand I, as a physician, have been extremely satisfied with the results.Patients are specifically pleased with the pain-free, 'walk-in, walk out'nature of the procedure and the long-lasting body contouring effects,"affirmed Dr. Ascher.
Dr. Christopher Inglefield, Plastic Surgery Clinic at the London BridgeHospital in London, UK, will review results from his 500-patient clinicalexperience with UltraShape Contour I, in which he found an averagecircumference reduction of 6.3 cm and a patient satisfaction rate of 93%."UltraShape's innovative technology has proven to be a breakthrough in themedical aesthetics field. Adding this unique non-invasive technology to mypractice has attracted a significant amount of new non-surgical patients tomy clinic," stated Dr. Inglefield.
Dr. Hector Leal-Silva, Center for Dermatology and Cosmetic Surgery (CDCC)in Monterrey, Mexico, will discuss his clinical experience with UltraShapewhich showed definite measurable results after three treatments in 100% ofpatients, including an average of a 5 cm reduction in circumference anddocumented CT scan reduction of fat thickness. Ninety-four percent (94%) ofpatients were satisfied with the procedure. "UltraShape has addressed apreviously unmet patient need in my practice for a safe and effectivenon-invasive option for the reduction of localized fat deposits," said Leal.
Other physicians presenting clinical results with UltraShape at IMCASinclude:
- Dr. Michael Scheflan, M.D., Plastic Surgeon, Atidim Medigroup, Israel
- Dr. Wichai Hongcharu, Head of the Department of Dermatology at theSaint Louis Hospital, Bangkok, Thailand
- Dr. Jana Hercogova MD, PhD, from Charles University and BulovkaUniversity Hospital in Prague, CZ
- Dr. Dean Ad-El, Head of the Department of Plastic Surgery at RabinMedical Center, Israel
Rodger Stewart, UltraShape CEO stated, "UltraShape is honored to beparticipating, for the third time, in IMCAS, which has become a majorinternational meeting showcasing the latest innovations in medicalaesthetics. We are pleased that these independent studies continue toreinforce UltraShape findings and are encouraged by the increasing amount ofclinical data that affirms UltraShape's effectiveness and patientsatisfaction. The continual positive response from both physicians andpatients is a testament to our unique technology and confirms our leadershipposition in non-invasive fat reduction and body contouring."
About IMCAS
The International Master Course on Aging Skin (IMCAS) has become one ofthe largest, most influential and most representative of internationalconferences dedicated to the field of aesthetic surgery and cosmeticdermatology. By welcoming 2,600 delegates in each of our annual conferencescoming from 40 different countries, it represents a true "medical populationsam
